FarmaKology Newsletter - Issue #10
Avails Medical, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and health-care associated infections. As repeatedly stated by experts around the world, antimicrobial resistance could spell the end of modern medicine.
Pfizer's tafamidis wins blockbuster nod—and gets a lower price—to rival Alnylam, Ionis
Once rejected by the FDA, Pfizer’s tafamidis is back and ready to disrupt a rare disease field only recently tapped by Alnylam and Ionis. And the pharma giant's entrant, now dubbed Vyndaqel, comes with a much lower price tag.
Genentech’s Kadcyla Wins Second FDA Approval for HER2-Positive Breast Cancer
Twelve weeks after filing its supplemental Biologics License Application, Genentech’s Kadcyla secured approval from the U.S. Food and Drug Administration (FDA) for a second breast cancer indication.
China’s war on healthcare costs lures Sun Pharma to scale up business
Sun Pharmaceutical Industries is scouting for a partner in China to help it win a larger piece of the worlds second-largest drug market, where the government is on a mission to drive down healthcare costs.
Takeda Opens New Global Research Center in San Diego
Takeda has opening a new research facility in San Diego, CA. The 165,000-square-foot facility is home to more than 250 employees focused on leveraging specialized drug discovery technologies and advancing discovery research in gastroenterology and neuroscience.
Research & Study
Heart Attack and Stroke Risk Increase With Antibiotic Use in Women
Statin use lowers risk of joint replacement in rheumatoid arthritis
Vaccine design can dramatically improve cancer immunotherapies
Listen to 396: The Use Of Methylene Blue For The Treatment Of Refractory Anaphylaxis Without Hypotension and 299 other episodes by The Elective Rotation - A Critical Care Pharmacy Podcast. No signup or install required.